To support the credit facility issuance, Jamjoom Pharma provided a corporate guarantee of DZD 980 million (SAR 27.1 million) ...
Hosted on MSN1mon
Innate Pharma shares retain Buy rating on long-term strategyThe firm's positive outlook is anchored in the anticipated data from ... to Innate Pharma's broader ANKET pipeline portfolio, which includes the trifunctional anti-BCMA ANKET SARâ„¢514/IPH6401 ...
ICEYE and SATIM will enhance the use of SAR data by combining SAR imagery and advanced analytics. HELSINKI and KRAKOW, Poland, Feb. 10, 2025 /PRNewswire/ -- ICEYE, the global leader in Synthetic ...
According to data available with Argaam, Jamjoom Pharma’s board of directors approved providing a corporate guarantee to Natixis Algérie to support the issuance of a Shariah-compliant short-term ...
The data for this FTD submission was primarily focused on the results of the phase I/II COBRA study, which assessed the safety and diagnostic performance of 64Cu-SAR-bisPSMA in detecting prostate ...
Nuance Pharma ("Nuance") announced that the Pharmaceutical Administration Bureau Macau approved Ohtuvayreâ„¢ (ensifentrine) for the maintenance treatment of chronic obstructive pulmonary disease (COPD) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback